{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:27Z","timestamp":1786985427014,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703358"],"award-info":[{"award-number":["81703358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09711002-002-009"],"award-info":[{"award-number":["2018ZX09711002-002-009"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21S11908000"],"award-info":[{"award-number":["21S11908000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18ZR1437700"],"award-info":[{"award-number":["18ZR1437700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18QB1404200"],"award-info":[{"award-number":["18QB1404200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23DZ2292600"],"award-info":[{"award-number":["23DZ2292600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006683","name":"Xi\u2019an Jiaotong-Liverpool University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bmc.2024.117698","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T13:08:42Z","timestamp":1711458522000},"page":"117698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of aralkyl piperazine and piperidine derivatives targeting SSRI\/5-HT1A\/5-HT7"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-5141","authenticated-orcid":false,"given":"Jianwei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2008-1755","authenticated-orcid":false,"given":"Qingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117698_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","article-title":"Novel and emerging treatments for major depression","volume":"401","author":"Marwaha","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117698_b0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","article-title":"Time for united action on depression: a lancet-world psychiatric association commission","volume":"399","author":"Herrman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117698_b0015","unstructured":"World Health Organization. Depressive disorder (depression); 202https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/depression. Accessed 6 January 2024."},{"key":"10.1016\/j.bmc.2024.117698_b0020","year":"2019","journal-title":"Global Health Data Exchange (GHDx)"},{"key":"10.1016\/j.bmc.2024.117698_b0025","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.15252\/embr.201642951","article-title":"The economic costs of mental disorders: do our societies react appropriately to the burden of mental disorders?","volume":"17","author":"Trautmann","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bmc.2024.117698_b0030","first-page":"2299","volume":"392","author":"Malhi","year":"2018","journal-title":"DepressionLancet."},{"key":"10.1016\/j.bmc.2024.117698_b0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the Management of Adults with major depressive Disorder: section 3","volume":"61","author":"Kennedy","year":"2016","journal-title":"Pharmacological Treatments. Can J Psychiatry."},{"key":"10.1016\/j.bmc.2024.117698_b0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.abo3566","article-title":"Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN","volume":"378","author":"Sun","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bmc.2024.117698_b0045","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117698_b0050","first-page":"627","article-title":"STAR*D: revising conventional wisdom","volume":"23","author":"Rush","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bmc.2024.117698_b0055","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11065-018-9388-2","article-title":"Cognitive deficits in psychotic Disorders: a lifespan perspective","volume":"28","author":"Sheffield","year":"2018","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.bmc.2024.117698_b0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41398-022-02249-6","article-title":"Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research","volume":"12","author":"Colwell","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bmc.2024.117698_b0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S2215-0366(19)30278-0","article-title":"Cognitive impairment in people remitted from major depression","volume":"6","author":"Porter","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bmc.2024.117698_b0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2006.07.002","article-title":"Differentiating antidepressants of the future: efficacy and safety","volume":"113","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2024.117698_b0075","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/jcm8101640","article-title":"Management strategies for antidepressant-related sexual dysfunction: a clinical approach","volume":"8","author":"Montejo","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.bmc.2024.117698_b0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pbb.2013.11.003","article-title":"Antidepressant-induced sexual dysfunction in men","volume":"121","author":"Segraves","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bmc.2024.117698_b0085","doi-asserted-by":"crossref","unstructured":"Fava M. Weight gain and antidepressants. J Clin Psychiatry. 2000;61 Suppl 11:37-41.","DOI":"10.4088\/JCP.v61n1109"},{"key":"10.1016\/j.bmc.2024.117698_b0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/138945006775515446","article-title":"Pindolol augmentation of antidepressant response","volume":"7","author":"Artigas","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bmc.2024.117698_b0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4306\/pi.2015.12.2.155","article-title":"Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of action","volume":"12","author":"Wang","year":"2015","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.bmc.2024.117698_b0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/17460441.2016.1160051","article-title":"The preclinical and clinical effects of vilazodone for the treatment of major depressive Disorder","volume":"11","author":"Sahli","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2024.117698_b0105","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1021\/acs.jmedchem.7b01898","article-title":"Structure-activity relationships and therapeutic potentials of 5-HT7 receptor ligands: an update","volume":"61","author":"Modica","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117698_b0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/acschemneuro.8b00283","article-title":"Pharmacology and therapeutic potential of the 5-HT7 receptor","volume":"10","author":"Blattner","year":"2019","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.bmc.2024.117698_b0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuropharm.2013.01.023","article-title":"Effects of lurasidone in behavioral models of depression. role of the 5-HT\u2087 receptor subtype","volume":"70","author":"Cates","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmc.2024.117698_b0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/jpet.112.193995","article-title":"Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive Disorder","volume":"342","author":"Bonaventure","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2024.117698_b0125","article-title":"Current limitations and candidate potential of 5-HT7 receptor antagonism in psychiatric Pharmacotherapy","volume":"12","author":"Okubo","year":"2021","journal-title":"Front Psych"},{"key":"10.1016\/j.bmc.2024.117698_b0130","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/ijms22031351","article-title":"Effects of subchronic administrations of vortioxetine, Lurasidone, and escitalopram on thalamocortical glutamatergic transmission associated with serotonin 5-HT7 receptor","volume":"22","author":"Okada","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117698_b0135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.107.119404","article-title":"Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents","volume":"321","author":"Bonaventure","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2024.117698_b0140","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.bmcl.2017.11.007","article-title":"Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"27","author":"Gu","year":"2017","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.bmc.2024.117698_b0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejmech.2017.12.063","article-title":"Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"144","author":"Gu","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117698_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126703","article-title":"Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"29","author":"Gu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117698_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126769","article-title":"Synthesis and antidepressant-like activity of novel alkoxy-piperidine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"29","author":"Wang","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117698_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment: useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117698_b0165","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1021\/jm049702f","article-title":"Structure-affinity relationship study on N-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-piperazinealkylamides, a new class of 5-Hydroxytryptamine7 receptor agents","volume":"47","author":"Leopoldo","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117698_b0170","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/cbdd.12539","article-title":"Solid-supported synthesis and 5-HT7 \/5-HT1A receptor affinity of arylpiperazinylbutyl derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one","volume":"86","author":"Grychowska","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2024.117698_b0175","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bmcl.2015.02.042","article-title":"Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT(1)A and 5-HT(7) receptor ligands","volume":"25","author":"Modica","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117698_b0180","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature17629","article-title":"X-ray structures and mechanism of the human serotonin transporter","volume":"532","author":"Coleman","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117698_b0185","doi-asserted-by":"crossref","unstructured":"Coleman JA, Navratna V, Antermite D, Yang D, Bull JA, Gouaux E. Chemical and structural investigation of the paroxetine-human serotonin transporter complex. Elife. 2020;9:e56427. https:\/\/dx.doi. org\/10.7554\/eLife.56427.","DOI":"10.7554\/eLife.56427"},{"key":"10.1016\/j.bmc.2024.117698_b0190","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41467-020-15292-y","article-title":"The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter","volume":"11","author":"Plenge","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2024.117698_b0195","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1039\/C9CP05764A","article-title":"The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations","volume":"22","author":"Zhang","year":"2020","journal-title":"PCCP"},{"key":"10.1016\/j.bmc.2024.117698_b0200","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1038\/s41467-021-25363-3","article-title":"The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter","volume":"12","author":"Plenge","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2024.117698_b0205","doi-asserted-by":"crossref","first-page":"28885","DOI":"10.1039\/C7CP05688E","article-title":"Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT(1A) receptor in the treatment of major depressive disorder","volume":"19","author":"Zheng","year":"2017","journal-title":"PCCP"},{"key":"10.1016\/j.bmc.2024.117698_b0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","article-title":"Structural insights into the lipid and ligand regulation of serotonin receptors","volume":"592","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117698_b0215","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.molcel.2022.05.031","article-title":"GPCRs steer G(i) and G(s) selectivity via TM5-TM6 switches as revealed by structures of serotonin receptors","volume":"82","author":"Huang","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2024.117698_b0220","doi-asserted-by":"crossref","first-page":"43694","DOI":"10.1074\/jbc.M112.342212","article-title":"Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket","volume":"287","author":"Sorensen","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117698_b0225","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.bmc.2024.117698_b0230","doi-asserted-by":"crossref","unstructured":"Castagne V, Moser P, Roux S, Porsolt RD. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Pharmacol. 2010;Chapter 5: Unit 5.8. DOI: 10.1002\/0471141755.ph0508s49.","DOI":"10.1002\/0471141755.ph0508s49"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:32:07Z","timestamp":1778574727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"alternative-id":["S0968089624001123"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117698","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of aralkyl piperazine and piperidine derivatives targeting SSRI\/5-HT1A\/5-HT7","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117698"}}